Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2021, Vol. 48 Issue (2): 426-430    DOI: 10.31083/j.ceog.2021.02.2260
Case Report Previous articles | Next articles
A giant placental chorioangioma with a resultant live birth; a discussion of management options
Saša Raičević1, *(), Duško Kljakić2, , Filip Vukmirović3, Miloš Z. Milosavljević4
1Clinic of Gynecology and Obstetrics, Clinical Center of Montenegro, University of Montenegro, 81000 Podgorica, Montenegro
2Department of Gynecology, 85000 General Hospital Bar, Montenegro
3Department of Pathology, Clinical Center of Montenegro, University of Montenegro, 81000 Podgorica, Montenegro
4Department of Pathology, University Medical Center Kragujevac, 34000 Kragujevac, Serbia
Download:  PDF(4847KB)  ( 282 ) Full text   ( 30 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Introduction: Chorioangiomas are benign, nontrophoblastic tumors of the placenta. Giant chorioangiomas (larger 5 cm) are infrequent and have unfavorable outcomes due to their strong association with maternal and fetal complications. We describe a case of a giant chorioangioma that had a good outcome without complications. Case report: A 27-year-old woman, primipara, with a regularly monitored pregnancy was admitted to the hospital at 37 + 5 weeks of gestation due to pain in the lower half of the abdomen, rupture of the amniotic sac and accumulation of thick, green, amniotic fluid. Ultrasonography performed at 33 weeks of gestation indicated the presence of a tumor mass 12.5 × 7.7 cm in diameter that was localized near the chorionic surface. Cardiotocography indicated variable decelerations, which necessitated an emergency cesarean section. A live, healthy, male child was born without complications via Dorfler's cesarean section. The encapsulated tumor mass was manually removed from the uterus, and angiomatous chorioangioma of the placenta was diagnosed by pathohistological examination. Conclusion: Ultrasonographic monitoring is the choice method for the accurate diagnosis and intervention of chorioangioma, but only pathohistological examination can confirm the diagnosis. This case report demonstrates that giant placental chorioangioma may have a favorable outcome without any medical intervention.
Key words:  Complications      Placental chorioangioma      Prenatal diagnosis      Color Doppler      Placenta      Tumor      Ultrasonography      Immunohistochemistry     
Submitted:  19 August 2020      Revised:  17 October 2020      Accepted:  21 October 2020      Published:  15 April 2021     
*Corresponding Author(s):  Saša Raičević     E-mail:  sasar@doctor.com
About author:  Dead author.

Cite this article: 

Saša Raičević, Duško Kljakić, Filip Vukmirović, Miloš Z. Milosavljević. A giant placental chorioangioma with a resultant live birth; a discussion of management options. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 426-430.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog.2021.02.2260     OR     https://ceog.imrpress.com/EN/Y2021/V48/I2/426

[1] Yu Huang, Fang-Yuan Luo. Clinical efficacy of aortic balloon occlusion during caesarean section in patients with placenta accreta spectrum disorders: a systematic review and meta-analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 234-244.
[2] Kumari Anukriti, Kiran Guleria, Vipin Tyagi, Amita Suneja, B D Banerjee. Maternal blood and amnionic oxytocin receptor gene expression and serum oxytocin levels in preterm birth: a case-control study[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 283-291.
[3] Ryuichi Shimaoka, Tomomi Shiga, Ken-ichirou Morishige. Change in uterine artery blood flow with intrauterine balloon tamponade[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 307-311.
[4] Xiao-Hua Li, Jian-Kun Zhou, Jing-Dan Cheng. Application of ultrasound in hepatic pregnancy: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 434-438.
[5] Suchaya Luewan, Pakorn Chaksuwat, Tip Pongsuvareeyakul, Theera Tongsong. Prenatal sonographic findings and management of placental mesenchymal dysplasia[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 439-443.
[6] Sureyya Saridas Demir, Erkan Cağliyan, Sabahattin Altunyurt. Retrospective analysis of pregnancy terminations and indications in a tertiary center[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 85-90.
[7] L. Lamprou, G. Panagopoulou, N. Papadopoulos, C. Tsigalou, O. Pagonopoulou, M. Lambropoulou. Impact of chorioamnionitis and other intrauterine pathological conditions on human foetal cytoskeleton structural protein development: An immunohistochemical study[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 856-861.
[8] D. Filipecka-Tyczka, A. Kajdy, B.P. Siekierski, M. Stańczyk, A. Rogowski, M. Rabijewski, R.B. Maksym. Deep infiltrating endometriosis as a cause of severe urogynecological complications despite invasive treatment - report of two cases from the center of endometriosis surgery[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 955-960.
[9] Y.J. Wu, C.J. Yu, W.H. Tian, Z. Xu. Prenatal diagnosis and molecular cytogenetic characterization of two hereditary chromosomal duplications with favorable outcomes[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 789-791.
[10] G. Zhu, S.J. Liu, W. Lv. Bilateral borderline ovarian cystadenoma with migration of intrauterine device to right ovary accompanied with endometrial carcinoma in situ: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 781-784.
[11] H.M. Kim, Y.J. Chin, H.H. Cha, W.J. Seong, M.J. Kim. Placenta accreta and uterine rupture of unscarred uterus in patients with systemic lupus erythematosus with prolonged steroid exposure: a report of two cases[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 785-788.
[12] G. Garuti, E. Castellacci, S. Calabrese, S. Calzolari. Hysteroscopic removal of retained products of conception with enhanced vascularity: a study of reliability[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 472-477.
[13] J.Y. Yan, P.P. Chen, L.L. Jiang, H.L. Zhang, Q. Han, R.X. Chen, Q.J. Zhang. Exploration on the relationship between hypoxia inducible factor-1α and morbidly adherent placenta[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 565-570.
[14] Y. Wang, X.Y. Lu, F. Xu, H.M. Huang, Y. Xu, X.W. Xi. Detection of uterine artery hemodynamic changes in patients with gestational hypertension based on Doppler ultrasonography[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 584-589.
[15] B.F. Zhou, C.X. Duan, D.L. Tang. Methylmalonic acidemia in prenatal diagnosis[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 617-619.
[1] Eli M. Roth, Michael H. Davidson. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 31 -46 .
[2] Sandeep K. Krishnan, Norman E. Lepor. Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management[J]. Reviews in Cardiovascular Medicine, 2016, 17(S1): 9 -21 .
[3] Ibrahim Sidiqi, Patrick Alexander. Current Advances in Endovascular Therapy for Infrapopliteal Artery Disease[J]. Reviews in Cardiovascular Medicine, 2015, 16(1): 36 -50 .
[4] Prakash C. Deedwania. Management of Patients With Stable Angina and Type 2 Diabetes[J]. Reviews in Cardiovascular Medicine, 2015, 16(2): 105 -113 .
[5] Peter Shalit. Management of Dyslipidemia in Patients With Human Immunodeficiency Virus[J]. Reviews in Cardiovascular Medicine, 2014, 15(S1): 38 -46 .
[6] Sophie Mavrogeni, Fabrizio Cantini, Gerald M. Pohost. Systemic Vasculitis: An Underestimated Cause of Heart Failure—Assessment by Cardiovascular Magnetic Resonance[J]. Reviews in Cardiovascular Medicine, 2013, 14(1): 49 -55 .
[7] Jeffrey W. Moses, Stephane Carlier, Issam Moussa. Lesion Preparation Prior to Stenting[J]. Reviews in Cardiovascular Medicine, 2004, 5(S2): 16 -21 .
[8] Michael A. Weber. The Effects on Dementia of Long-Term Treatment of Hypertension[J]. Reviews in Cardiovascular Medicine, 2003, 4(3): 197 -198 .
[9] M. Pakiž, L. Lukman, N. Kozar. Patients' and physicians' expectations differ significantly during the follow-up period after completion of primary treatment of gynecological or breast cancer[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 781 -786 .
[10] T. Tomimatsu, S. Mabuchi, T. Tsuboyama, Y. Hori, S. Sekine, T. Kimura. Malignant transformation of uterine leiomyoma: suggested by clinical, imaging, histological, and genetic findings[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 879 -882 .